The High Response Rates in First Line Chemotherapy

Luis: Response rates were greater than 50% when we're looking at first line. When we look at all comers, it's still in the 30 plus percent range. So that's encouraging. And I think it supports their, they're going to move into big phase three. Louisa: The other issue is, you know, data as a single agent in second line versus dose of tax. You know, maybe that's where it's going to start out.